Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model

Human Gene Therapy

Volumn 20, Issue 8, 2009, Pages 897-907

  Keeney, Paula M ^a   Quigley, Caitlin K ^a   Dunham, Lisa D ^a   Papageorge, Christina M ^a   Iyer, Shilpa ^a   Thomas, Ravindar R ^a   Schwarz, Kathleen M ^a   Trimmer, Patricia A ^a   Khan, Shaharyar M ^b   Portell, Francisco R ^b   Bergquist, Kristen E ^a   Bennett Jr , James P ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Gencia Corporation   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; CYBRID; GENE THERAPY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; PARKINSON DISEASE;

CELL LINE, TUMOR; CELL RESPIRATION; DNA, MITOCHONDRIAL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE THERAPY; GENES, MITOCHONDRIAL; HUMANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; PARKINSON DISEASE; PROTEIN SORTING SIGNALS; PROTEIN STRUCTURE, TERTIARY; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANSCRIPTION FACTORS;

EID: 68949206326     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.023     Document Type: Article

References (42)

1. Bannwarth, S., Procaccio, V., and Paquis-Flucklinger, V. (2005). Surveyor nuclease: A new strategy for a rapid identification of heteroplasmic mitochondrial DNA mutations in patients with respiratory chain defects. Hum. Mutat. 25, 575-582.
2. Bannwarth, S., Procaccio, V., and Paquis-Flucklinger, V. (2006). Rapid identification of unknown heteroplasmic mutations across the entire human mitochondrial genome with mismatch-specific Surveyor nuclease. Nat. Protoc. 1, 2037-2047.
3. Bender, A., Krishnan, K.J., Morris, C.M., Taylor, G.A., Reeve, A.K., Perry, R.H., Jaros, E., Hersheson, J.S., Betts, J., Klopstock, T., Taylor, R.W., and Turnbull, D.M. (2006). High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 38, 515-517.
4. Bender, A., Schwarzkopf, R.M., McMillan, A., Krishnan, K.J., Rieder, G., Neumann, M., Elstner, M., Turnbull, D.M., and Klopstock, T. (2008). Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions. J. Neurol. 255, 1231-1235.
5. Bogenhagen, D.F., Rousseau, D., and Burke, S. (2008). The layered structure of human mitochondrial DNA nucleoids. J. Biol. Chem. 283, 3665-3675.
6. Borland, M.K., Trimmer, P.A., Rubinstein, J.D., Keeney, P.M., Mohanakumar, K.P., Liu, L., and Bennett, J.P., Jr. (2008). Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson's disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cells. Mol. Neurodegener. 3, 21.
7. Borland, M.K., Mohanakumar, K.P., Rubinstein, J.D., Keeney, P.M., Xie, J., Capaldi, R., Dunham, L.D., Trimmer, P.A., and Bennett, J.P., Jr. (2009). Relationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues. Biochim. Biophys. Acta 1792, 68-74.
8. Cassarino, D.S., Fall, C.P., Swerdlow, R.H., Smith, T.S., Halvorsen, E.M., Miller, S.W., Parks, J.P., Parker, W.D., Jr., and Bennett, J.P., Jr. (1997). Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim. Biophys. Acta 1362, 77-86.
9. Dimauro, S., and Schon, E.A. (2008). Mitochondrial disorders in the nervous system. Annu. Rev. Neurosci. 31, 91-123.
10. Ekstrand, M.I., Falkenberg, M., Rantanen, A., Park, C.B., Gaspari, M., Hultenby, K., Rustin, P., Gustafsson, C.M., and Larsson, N.G. (2004). Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum. Mol. Genet. 13, 935-944.
11. Ekstrand, M.I., Terzioglu, M., Galter, D., Zhu, S., Hofstetter, C., Lindqvist, E., Thams, S., Bergstrand, A., Hansson, F.S., Trifunovic, A., Hoffer, B., Cullheim, S., Mohammed, A.H., Olson, L., and Larsson, N.G. (2007). Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc. Natl. Acad. Sci. U.S.A. 104, 1325-1330.
12. Garstka, H.L., Schmitt, W.E., Schultz, J., Sogl, B., Silakowski, B., Perez-Martos, A., Montoya, J., and Wiesner, R.J. (2003). Import of mitochondrial transcription factor A (TFAM) into rat liver mitochondria stimulates transcription of mitochondrial DNA. Nucleic Acids Res. 31, 5039-5047.
13. Ghosh, S.S., Swerdlow, R.H., Miller, S.W., Sheeman, B., Parker, W.D., Jr., and Davis, R.E. (1999). Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease. Ann. N. Y. Acad. Sci. 893, 176-191.
14. Gnaiger, E. (2003). Oxygen conformance of cellular respiration: A perspective of mitochondrial physiology. Adv. Exp. Med. Biol. 543, 39-55.
15. Gu, M., Cooper, J.M., Taanman, J.W., and Schapira, A.H. (1998). Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann. Neurol. 44, 177-186.
16. Holt, I.J., He, J., Mao, C.C., Boyd-Kirkup, J.D., Martinsson, P., Sembongi, H., Reyes, A., and Spelbrink, J.N. (2007). Mammalian mitochondrial nucleoids: Organizing an independently minded genome. Mitochondrion 7, 311-321.
17. Hutter, E., Unterluggauer, H., Garedew, A., Jansen-Durr, P., and Gnaiger, E. (2006). High-resolution respirometry: A modern tool in aging research. Exp. Gerontol. 41, 103-109.
18. Iyer, S., Thomas, R.R., Portell, F.R., Dunham, L.D., Quigley, C.K., Bennett, J.P., Jr. (2009). Recombinant mitochondrial transcription factor A with N-terminal mitochondrial transduction domain increases respiration and mitochondrial gene expression. Mitochondrion (in press).
19. Kang, D., Kim, S.H., and Hamasaki, N. (2007). Mitochondrial transcription factor A (TFAM): Roles in maintenance of mtDNA and cellular functions. Mitochondrion 7, 39-44.
20. Khan, S.M., and Bennett, J.P., Jr. (2004). Development of mitochondrial gene replacement therapy. J. Bioenerg. Biomembr. 36, 387-393.
21. Kosel, S., Hofhaus, G., Maassen, A., Vieregge, P., and Graeber, M.B. (1999). Role of mitochondria in Parkinson disease. Biol. Chem. 380, 865-870.
22. Kraytsberg, Y., Kudryavtseva, E., McKee, A.C., Geula, C., Kowall, N.W., and Khrapko, K. (2006). Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat. Genet. 38, 518-520.
23. Krishnan, K.J., Reeve, A.K., Samuels, D.C., Chinnery, P.F., Blackwood, J.K., Taylor, R.W., Wanrooij, S., Spelbrink, J.N., Lightowlers, R.N., and Turnbull, D.M. (2008). What causes mitochondrial DNA deletions in human cells? Nat. Genet. 40, 275-279.
24. Kucej, M., and Butow, R.A. (2007). Evolutionary tinkering with mitochondrial nucleoids. Trends Cell Biol. 17, 586-592.
25. Mukai, T., Matsubara, K., and Takagi, Y. (1973). Isolation of circular DNA molecules from whole cellular DNA by use of ATP-dependent deoxyribonuclease. Proc. Natl. Acad. Sci. U.S.A. 70, 2884-2887.
26. Parker, W.D., Jr., and Parks, J.K. (2005). Mitochondrial ND5 mutations in idiopathic Parkinson's disease. Biochem. Biophys. Res. Commun. 326, 667-669.
27. Pastukh, V., Shokolenko, I., Wang, B., Wilson, G., and Alexeyev, M. (2007). Human mitochondrial transcription factor A possesses multiple subcellular targeting signals. FEBS J. 274, 6488-6499.
28. Pecina, P., Gnaiger, E., Zeman, J., Pronicka, E., and Houstek, J. (2004). Decreased affinity for oxygen of cytochrome-c oxidase in Leigh syndrome caused by SURF1 mutations. Am. J. Physiol. Cell. Physiol. 287, C1384-C1388.
29. Reeve, A.K., Krishnan, K.J., Elson, J.L., Morris, C.M., Bender, A., Lightowlers, R.N., and Turnbull, D.M. (2008). Nature of mitochondrial DNA deletions in substantia nigra neurons. Am. J. Hum. Genet. 82, 228-235.
30. Scarpulla, R.C., (2006). Nuclear control of respiratory gene expression in mammalian cells. J. Cell. Biochem. 97, 673-683.
31. Scarpulla, R.C. (2008). Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 88, 611-638.
32. Schapira, A.H. (1998). Mitochondrial dysfunction in neurodegenerative disorders. Biochim. Biophys. Acta 1366, 225-233.
33. Schapira, A.H., Gu, M., Taanman, J.W., Tabrizi, S.J., Seaton, T., Cleeter, M., and Cooper, J.M. (1998). Mitochondria in the etiology and pathogenesis of Parkinson's disease. Ann. Neurol. 44, S89-S98.
34. Smigrodzki, R., Parks, J., and Parker, W.D. (2004). High frequency of mitochondrial complex I mutations in Parkinson's disease and aging. Neurobiol. Aging 25, 1273-1281.
35. Smigrodzki, R.M., and Khan, S.M. (2005). Mitochondrial microheteroplasmy and a theory of aging and age-related disease. Rejuvenation Res. 8, 172-198.
36. Swerdlow, R.H. (2007). Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies. J. Neurosci. Res. 85, 3416-3428.
37. Swerdlow, R.H., Parks, J.K., Miller, S.W., Tuttle, J.B., Trimmer, P.A., Sheehan, J.P., Bennett, J.P., Jr., Davis, R.E., and Parker, W.D., Jr. (1996). Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40, 663-671.
38. Trimmer, P.A., and Borland, M.K. (2005). Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement. Antioxid. Redox Signal. 7, 1101-1109.
39. Trimmer, P.A., Borland, M.K., Keeney, P.M., Bennett, J.P., Jr., and Parker, W.D., Jr. (2004). Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies. J. Neurochem. 88, 800-812.
40. Wallace, D.C. (2002). Animal models for mitochondrial disease. Methods Mol. Biol. 197, 3-54.
41. Wallace, D.C. (2005). A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu. Rev. Genet. 39, 359-407.
42. Wang, Y., and Bogenhagen, D.F. (2006). Human mitochondrial DNA nucleoids are linked to protein folding machinery and metabolic enzymes at the mitochondrial inner membrane. J. Biol. Chem. 281, 25791-25802.